Journal Club: Scoping review of prevalence of neurologic comorbidities in patients hospitalized for COVID-19

Coronavirus disease 2019 (COVID-19) is a global pandemic. As COVID-19 cases rise in different countries, neurologists and neurologists-in-training will be increasingly involved in the care of these patients from both a general medical and neurologic perspective. In the same way, patients with preexisting neurologic conditions are in no way exempt from acquiring this infection. On the other hand, new-onset neurologic manifestations have also been recently reported in previously healthy people infected with severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2).1 It is essential for neurologists and neurologists-in-training to be aware of the repercussions that COVID-19 may have in our daily practice.

Source link

Related posts

Differential diagnosis of apogeotropic positional nystagmus in the emergency room


Long-term health-related quality of life in 262 patients with brain arteriovenous malformation


Frontotemporal dementia affects moral emotions


This website uses cookies to improve your experience. We'll assume you're ok with this, but you can opt-out if you wish. Accept Read More

Privacy & Cookies Policy